Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
260 GBX | +13.79% | +22.35% | +18.18% |
Apr. 29 | FTSE 100 as investors look to Fed rate decision | AN |
Apr. 29 | Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.18% | 326M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.46% | 22.18B | |
-16.67% | 21.2B | |
-8.58% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Sio Gene Therapies Terminates Oxford Biomedica's Parkinson's Disease Gene Therapy Program